Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Unsworth

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Regenerative Medicine|December 16, 2016
Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacyDavid J Unsworth, Jane L Mathias, Diana S Dorstyn
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 1, 2019
Preliminary Screening Recommendations for Patients at Risk of Depression and/or Anxiety more than 1 year PoststrokeDavid J Unsworth, Jane L Mathias, Diana S Dorstyn
Annals of Clinical Biochemistry|June 17, 2015
Low plasma viscosity as an indicator of antibody deficiencyRobert J Lock, Philip D Bright, David J Unsworth
Annals of Clinical Biochemistry|July 2, 2011
Immunoglobulin E deficiency: a forgotten clue pointing to possible immunodeficiency?David J Unsworth, Paul F Virgo, Robert J Lock
BMJ (Clinical Research Ed.)|December 12, 2012
Targeting coeliac disease serologyDavid J Unsworth, Francis J Smith, Robert J Lock
Transplantation|May 16, 2014
Immune hemolysis resulting from passenger lymphocyte syndrome derived anti-rh (D) reactivity after kidney transplantation: a case report and literature reviewPrashanth Karanth, Janet Birchall, Sarinder Day, et al.
European Journal of Gastroenterology & Hepatology|April 21, 2004
Anti-tissue transglutaminase antibodies in coeliac disease are not a response to gut damage aloneDavid J Unsworth, Maxton C L Pitcher, Susan Stevens, et al.
Disability and Rehabilitation|February 2, 2019
Stroke survivor attitudes toward, and motivations for, considering experimental stem cell treatmentsDavid J Unsworth, Jane L Mathias, Diana S Dorstyn, et al.
European Journal of Gastroenterology & Hepatology|April 21, 2004
Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?Robert J Lock, Susan Stevens, Maxton C L Pitcher, et al.
Journal of Immunological Methods|November 19, 2013
A simple immunofixation test for induced C3 degradation in disease states (including C3 nephritic factor) and its correlation with kidney biopsyEsha Sarkar, Ellen G Roberts, Michael J Wallage, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Regenerative Medicine|December 16, 2016
Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacyDavid J Unsworth, Jane L Mathias, Diana S Dorstyn
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 1, 2019
Preliminary Screening Recommendations for Patients at Risk of Depression and/or Anxiety more than 1 year PoststrokeDavid J Unsworth, Jane L Mathias, Diana S Dorstyn
Annals of Clinical Biochemistry|June 17, 2015
Low plasma viscosity as an indicator of antibody deficiencyRobert J Lock, Philip D Bright, David J Unsworth
Annals of Clinical Biochemistry|July 2, 2011
Immunoglobulin E deficiency: a forgotten clue pointing to possible immunodeficiency?David J Unsworth, Paul F Virgo, Robert J Lock
BMJ (Clinical Research Ed.)|December 12, 2012
Targeting coeliac disease serologyDavid J Unsworth, Francis J Smith, Robert J Lock
Transplantation|May 16, 2014
Immune hemolysis resulting from passenger lymphocyte syndrome derived anti-rh (D) reactivity after kidney transplantation: a case report and literature reviewPrashanth Karanth, Janet Birchall, Sarinder Day, et al.
European Journal of Gastroenterology & Hepatology|April 21, 2004
Anti-tissue transglutaminase antibodies in coeliac disease are not a response to gut damage aloneDavid J Unsworth, Maxton C L Pitcher, Susan Stevens, et al.
Disability and Rehabilitation|February 2, 2019
Stroke survivor attitudes toward, and motivations for, considering experimental stem cell treatmentsDavid J Unsworth, Jane L Mathias, Diana S Dorstyn, et al.
European Journal of Gastroenterology & Hepatology|April 21, 2004
Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?Robert J Lock, Susan Stevens, Maxton C L Pitcher, et al.
Journal of Immunological Methods|November 19, 2013
A simple immunofixation test for induced C3 degradation in disease states (including C3 nephritic factor) and its correlation with kidney biopsyEsha Sarkar, Ellen G Roberts, Michael J Wallage, et al.
Pageof 3